ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 274553 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 274553; 2) Community: the network communities that were significantly associated with the response to NSC 274553; 3) Molecule: the relationships between components within communities and NSC 274553; 4) MDR: the compounds that were significantly associated with the NSC 274553.

NSC Compound Enrichment Correlation
NSC 757925 3,5-bis(4-hydroxy-3-methoxystyryl)-N-(4-fluorophenyl)-1H-pyrazole-1-carboxamide 0.0174989034030623 0.34902846
NSC 759274 ARSENIC TRIOXIDE 0.0174989034030623 0.50570927
NSC 118218 2-Fluoro Ara A 0.0201565205286438 0.13793906
NSC 19441 FDA 0283 0.0201565205286438 0.011038284
NSC 600301 Null 0.020156520528644 0.71525955
NSC 666302 Null 0.020156520528644 0.60332738
NSC 34475 Androst-5-en-16.beta.-ol, 3.beta.-methoxy- (8CI) 0.0201565205286441 0.32413089
NSC 50273 Pyridine, 3-[[4-[bis(2-chloroethyl)amino]-2-methylbenzylidene]amino]- 0.0201565205286441 -0.065846578
NSC 705323 Null 0.0201565205286441 0.43817184
NSC 724065 (3,5-dibromo-2-hydroxy-benzylidene-hydrazinocarbonylmethylsu lfanyl)acetic acid (3,5-dibromo-2-hydroxy-benzylidene)-hydrazide 0.0201565205286441 0.21202265
Total:105  Current:49    [First] [Prev] [Next] [Last]